A novel antibody AA98 VH/L directed against CD146 efficiently inhibits angiogenesis

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 4219-4224

  Lin, Yun ^a,b   Wu, Xiaoping ^a,c   Shen, Yi ^a   Bu, Pengcheng ^a   Yang, Dongling ^a   Yan, Xiyun ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c PUGET SOUND BLOOD CENTER   (United States)

Author keywords

Angiogenesis; CD146; VH L single chain antibody

Indexed keywords

AA98 ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGENICITY; MOLECULAR CLONING; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD146; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL CELLS; EPITOPES; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 37549050086     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Tissue Antigens. 6th International Workshop and Conference on Human Leukocyte Differentiation Antigens. Kobe, Japan, November 10-14, 1996. Abstracts. : 417-419, 1996.
2. Folkman J. Antiagiogenic therapy. In: Cancer: Principles & Practice of Oncology. DeVita VT Jr, Hellman S and Rosenberg SA (eds.). Fifth Edition. Lippincott-Raven Publishers. Philadelphis Pennsylvania, pp: 3075-3085, 1997.
3. Takahashi Y, Kitadai Y and Bucana CD: Expression of vascular endothelial growth factor and its receptors, KDR, correlate with vascularity, metastasis and proliferation of human colon cancer. Cancer Res 55(18): 3964-3968, 1995.
4. Nguyen M, Strubel NA and Bischoff J: A role for sialy Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365(6443): 267-269, 1993.
5. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G and Cheresh DA: Integrin ανβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79(7): 1157-1164, 1994.
6. Yan X, Lin Y, Yang D, Shen Y, Yuan M, Zhang Z, Li P, Xia H, Li L, Luo D, Liu Q, Mann K and Bader BL: A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102(1): 184-191, 2003.
7. Lehmann J M, Riethmuler G and Johnson JP: MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 86(24): 9891-9895, 1989.
8. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B and Kinzler KW: Genes expressed in human tumor endothelium. Science 289(5482): 1197-1202, 2000
9. Bardin N, Anfosso F, Massé JM, Cramer E, Sabatier F, Le Bivic A, Sampol J and Dignat-George F: Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 98(13): 3677-3684, 2001.
10. H/κ) expressed in Escherichia coli. Immunology 84(4): 662-668, 1995.
11. Huston JS, Tain NS, Mudgett-Hunter M, McCartney J, Warren F, Haber E and Oppermann H: Protein engineering of single-chain Fv analogues and fusion protein. In: Molecular Design and Modeling: Concepts and Application, Part B. Langone JJ, (ed). Methods on Enzymology 203: 46-88, 1991.
12. Powers DB, Amersdorfer P, Poul M, Nielsen UB, Shalaby MR, Adams GP, Weiner LM and Marks JD: Expression of single-chain Fv-Fc fusions in Pichia pastoris. J Immunol Methods 251(1-2): 123-135, 2001.
13. H/κ. Progress of Biophysics and Biochemistry 29(1): 645-650, 2002.
14. Goel A, Baranowska-Kortylewicz J, Hinrichs SH, Wisecarver J, Pavlinkova G, Augustine S, Colcher D, Booth BJ and Batra SK: 99mTc-labeled divalent and tetravalent CC49 single-chain Fvs: novel imaging agents for rapid in vivo localization of human colon carcinoma. J Nucl Med 42(10): 1519-1527, 2001.
15. Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD and Weiner LM: High affinity restricts the localization and tumor penetration of single-chain Fv antibody molecules. Cancer Res 61(12): 4750-4755, 2001.
16. Nielsen UB, Adams GP, Weiner LM and Marks JD: Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity. Cancer Res 60(22): 6434-6440, 2000.
17. Casey JL, Napier MP, King DJ, Pedley RB, Chaplin LC, Weir N, Skelton L, Green AJ, Hope-Stone LD, Yarranton GT and Begent RH: Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study. Br J Cancer 86(9): 1401-1410, 2002.
18. Sanz L, Kristensen P, Blanco B, Facteau S, Russell SJ, Winter G and Alvarez-Vallina L: Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices. Gene Ther 9(15): 1049-1053, 2002.
19. Pasquier E, Bardin N, De Saint Martin L, Le Martelot MT, Bohec C, Roche S, Mottier D and Dignat-George F: The first assessment of soluble CD146 in women with unexplained pregnancy loss. A new insight? Thromb Haemost 94(6): 1280-1284, 2005.
20. Rheumatol J, Figarella-Branger D, Schleinitz N, Boutière- Albanèse B, Camoin L, Bardin N, Guis S, Pouget J, Cognet C, Pellissier JF and Dignat-George F: Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies 33(8): 1623-1630, 2006.
21. Duda DG, Cohen KS, di Tomaso E, Au P, Klein RJ, Scadden DT, Willett CG and Jain RK: Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J Clin Oncol 24(9): 1449-1453, 2006.